Skip to main content Accessibility help

Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis

  • E. Papada (a1), A. C. Kaliora (a2), A. Gioxari (a2), A. Papalois (a3) and A. Forbes (a1)...


The aim of the present study was to evaluate the effectiveness of two isoenergetic elemental formulae with different fat content in the rat model of trinitrobenzene sulphonic acid (TNBS) colitis that mimics human inflammatory bowel disease. A total of forty-five male Wistar rats were assigned to five groups: (1) control group; (2) TNBS-induced colitis group; (3) TNBS-induced colitis group fed a long-chain TAG (LCT)-rich diet; (4) TNBS-induced colitis group fed a medium-chain TAG (MCT)-rich diet; (5) TNBS-induced colitis group fed a baseline diet and administered infliximab. Nutritional management lasted 12 d before and 4 d after rectal administration of TNBS. Subsequently, the rats were killed, and colonic tissue samples were collected for the assessment of histology, inflammation and oxidative stress. The MCT-rich diet decreased IL-6, IL-8 and intercellular adhesion molecule-1 (ICAM-1) levels and glutathione S-transferase (GST) activity, while the LCT-rich diet reduced only ICAM-1 levels and GST activity (P< 0·05). Neither elemental formula affected IL-10 levels. Infliximab reduced IL-8 and ICAM-1 levels and GST activity and increased IL-10 levels (P< 0·05). No significant differences were detected in oxidative stress. Histological damage scores differed significantly only between the control and the TNBS-induced colitis group. A MCT-rich formula seems to exert stronger anti-inflammatory effects than a LCT-rich formula in TNBS colitis.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Anti-inflammatory effect of elemental diets with different fat composition in experimental colitis
      Available formats


Corresponding author

* Corresponding author: Professor A. Forbes, email


Hide All
1 Lakatos, PL (2006) Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 12, 61026108.
2 Loftus, EV (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 15041517.
3 Viscido, A, Aratari, A, Maccioni, F, et al. (2005) Inflammatory bowel diseases: clinical update of practical guidelines. Nucl Med Commun 26, 649655.
4 Bouma, G & Strober, W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3, 521533.
5 D'Odorico, A, Bortolan, S, Cardin, R, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36, 12891294.
6 Beltrán, B, Nos, P, Dasí, F, et al. (2010) Mitochondrial dysfunction, persistent oxidative damage and catalase inhibition in naive and treated Crohn's disease. Inflamm Bowel Dis 16, 7686.
7 Pithadia, AB & Jain, S (2011) Treatment of inflammatory bowel disease (IBD). Pharmacol Rep 63, 629642.
8 Feagan, BG, Lémann, M, Befrits, R, et al. (2012) Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. Inflamm Bowel Dis 18, 152160.
9 Forbes, A, Goldesgeyme, E & Paulon, E (2011) Nutrition in inflammatory bowel disease. J Parenter Enteral Nutr 35, 571580.
10 Bamba, T, Shimoyama, T, Sasaki, M, et al. (2003) Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol 15, 151157.
11 Middleton, SJ, Rucker, JT, Kirby, GA, et al. (1995) Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 14, 229236.
12 Zachos, M, Tondeur, M & Griffiths, AM (2007) Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Systematic Review CD000542.
13 Andoh, A, Takaya, H, Araki, Y, et al. (2000) Medium- and long-chain fatty acids differentially modulate interleukin-8 secretion in human fetal intestinal epithelial cells. J Nutr 130, 26362640.
14 Tsujikawa, T, Ohta, N, Nakamura, T, et al. (1999) Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid. J Gastroenterol Hepatol 14, 11661172.
15 Tsujikawa, T, Ohta, N, Nakamura, T, et al. (2001) Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis. J Gastroenterol 36, 673680.
16 Hassan, A, Ibrahim, A, Mbodji, K, et al. (2010) An α-linolenic acid-rich formula reduces oxidative stress and inflammation by regulating NF-κB in rats with TNBS-induced colitis. J Nutr 140, 17141721.
17 Kono, H, Fujii, H, Ogiku, M, et al. (2010) Enteral diets enriched with medium-chain triglycerides and n-3 fatty acids prevent chemically induced experimental colitis in rats. Transl Res 156, 282291.
18 Geboes, K, Riddell, R, Ost, A, et al. (2000) A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404409.
19 Bradford, MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem 72, 248254.
20 Kaliora, AC, Stathopoulou, MG, Triantafillidis, JK, et al. (2007) Chios mastic treatment of patients with active Crohn's disease. World J Gastroenterol 13, 748753.
21 Kwon, HK, Hwang, JS, Lee, CG, et al. (2011) Cinnamon extract suppresses experimental colitis through modulation of antigen-presenting cells. World J Gastroenterol 17, 976986.
22 Guerreiro, CS, Ferreira, P, Tavares, L, et al. (2009) Fatty acids, IL-6, and TNF-alpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am J Gastroenterol 104, 22412249.
23 Morris, GP, Beck, PL, Herridge, MS, et al. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795803.
24 Velde, A, Verstege, M & Hommes, D (2006) Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 12, 995999.
25 Mudter, J & Neurath, FM (2007) IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm Bowel Dis 13, 10161023.
26 Ito, H, Takazoe, M, Fukuda, Y, et al. (2004) A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 126, 989996.
27 Ina, K, Kusugami, K, Yamaguchi, T, et al. (1997) Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease. Am J Gastroenterol 92, 13421346.
28 MacDermott, RP (1999) Chemokines in the inflammatory bowel diseases. J Clin Immunol 19, 266272.
29 Danese, S, de la Motte, C, Sturm, A, et al. (2003) Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124, 12491264.
30 Nielsen, OH, Langholz, E, Hendel, J, et al. (1994) Circulating soluble intercellular adhesion molecule-1 (sICAM-1) in active inflammatory bowel disease. Dig Dis Sci 39, 19181923.
31 Kruidenier, L & Verspaget, HW (2002) Oxidative stress as a pathogenic factor in inflammatory bowel disease: radicals or ridiculous? Aliment Pharmacol Ther 16, 19972015.
32 Kruidenier, L, Kuiper, I, Van Duijn, W, et al. (2003) Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201, 1727.
33 Tüzün, A, Erdil, A, Inal, V, et al. (2002) Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 35, 569572.
34 Ademoglu, E, Erbil, Y, Tam, B, et al. (2004) Do vitamin E and selenium have beneficial effects on trinitrobenzenesulfonic acid-induced experimental colitis. Dig Dis Sci 49, 102108.
35 Girgin, F, Karaoglu, O, Erkuş, M, et al. (2000) Effects of trimetazidine on oxidant/antioxidant status in trinitrobenzenesulfonic acid-induced chronic colitis. J Toxicol Environ Health A 59, 641662.
36 Shah, S (2007) Dietary factors in the modulation of inflammatory bowel disease activity. MedGenMed 9, 60.
37 Fernández-Bañares, F, Cabré, E, González-Huix, F, et al. (1994) Enteral nutrition as primary therapy in Crohn's disease. Gut 34, Suppl. 1, S55S59.
38 Waitzberg, DL, Bellinati-Pires, R, Yamaguchi, N, et al. (1996) Influence of medium-chain triglyceride-based lipid emulsion on rat polymorphonuclear cell functions. Nutrition 12, 9399.
39 Wanten, GJ, Geijtenbeek, TB, Raymakers, RA, et al. (2000) Medium-chain triglyceride-containing lipid emulsions increase human neutrophil b2 integrin expression, adhesion, and degranulation. J Parenter Enteral Nutr 24, 228233.
40 Ohta, N, Tsujikawa, T, Nakamura, T, et al. (2003) A comparison of the effects of medium- and long-chain triglycerides on neutrophil stimulation in experimental ileitis. J Gastroenterol 38, 127133.
41 Evans, RC & Rhodes, JM (1996) Understanding the mechanism of dietary therapy in Crohn's disease – meta-analysis of polymeric enteral feeding studies and pilot study of maintenance with low fibre/low fat diet. Gut 38, A637.
42 Miura, S, Tsuzuki, Y, Hokari, R, et al. (1998) Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol 13, 11831190.
43 Leiper, K, Woolner, J, Mullan, MM, et al. (2001) A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 49, 790794.
44 Kuroki, F, Iida, M, Matsumoto, T, et al. (1997) Serum n3 polyunsaturated fatty acids are depleted in Crohn's disease. Dig Dis Sci 42, 11371141.
45 Ramakers, JD, Mensink, RP, Verstege, MI, et al. (2008) An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis. Br J Nutr 100, 347354.
46 Vieira de Barros, K, Gomes de Abreu, G, Xavier, RA, et al. (2011) Effects of a high fat or a balanced omega 3/omega 6 diet on cytokines levels and DNA damage in experimental colitis. Nutrition 27, 221226.
47 Bertevello, PL, De Nardi, L, Torrinhas, RS, et al. (2012) Partial replacement of ω-6 fatty acids with medium-chain triglycerides, but not olive oil, improves colon cytokine response and damage in experimental colitis. J Parenter Enteral Nutr 36, 442448.
48 Ibrahim, A, Mbodji, K, Hassan, A, et al. (2011) Anti-inflammatory and anti-angiogenic effect of long chain n-3 polyunsaturated fatty acids in intestinal microvascular endothelium. Clin Nutr 30, 678687.
49 Cho, JY, Chi, S-G & Chun, HS (2011) Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice. Mol Nutr Food Res 55, 239246.
50 Hou, JK, Abraham, B & El-Serag, H (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106, 563573.
51 Sakamoto, N, Kono, S, Wakai, K, et al. (2004) Dietary risk factors for inflammatory bowel disease: a multicenter case–control study in Japan. Inflamm Bowel Dis 11, 154163.
52 Gassull, MA, Fernandez-Banares, F, Cabre, E, et al. (2002) Fat composition may be a clue to explain the therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51, 164168.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed